Global Constipation-Laxative Market Overview:
The global constipation laxative market is set to witness steady growth, expanding at a CAGR of 5.7% during the forecast period (2020-2030). The market is set to reach a value pool of US$ 10.8 Bn through 2030. Opioid Induced Constipation (OIC) is the most prevalent side-effect post consumption of a certain class of drugs and may negatively impact patients’ adherence to analgesic prescriptions. OIC accounts for six out of ten non-cancer patients receiving opioids.
In addition, various metabolic disorders are also responsible for constipation. Diabetics are two times more susceptible to constipation than non-diabetic patients. Based on the aforementioned factors, the use of constipation laxatives has soared and will continue to find enhanced growth prospects in the future.
Global Constipation-Laxative Market Analysis by Mode of Mechanism
Bulk-forming laxatives are anticipated to capture the maximum market share, accounting for over one-third of the global constipation laxatives market throughout the forecast period. At the same time, the stimulants segment is poised to expand the fastest at a CAGR of 6.0%.
Ease of ingestion and gradual improvement of symptoms are the main factors behind increased preference for bulk-forming laxatives. Additionally, these laxatives also prevent the occurrence of explosive diarrhea, a common side-effect of stimulant laxatives. Bulk-forming laxatives also improve medical conditions such as hemorrhoids, anal fissures and hernia. Increased usage of stimulant-based laxatives is attributed to its immediate effectiveness, especially suppositories which work in as little as half-an-hour.
For answers to all the possible questions required for gauging the performance of the constipation-laxative market, get in touch with our expert analyst.
Global Constipation Laxative Market: Regional Insights:
North America and Europe collectively, shall account for over three-fifth of the global constipation-laxative market during the forecast period. While North America is poised to expand at a CAGR of ~5.5%, Europe shall expand at ~6.0%.
Increasing prevalence of constipation, growing awareness about gastrointestinal infections and increased support from the government to develop adequate healthcare infrastructure are some important factors driving market growth of constipation laxatives in North America and Europe.
Global Constipation Laxative Market Manufacturers
The global constipation-laxative market is consolidated. Prominent market players dominating the market include: GlaxoSmithKline, Bayer AG, Sanofi, Takeda, Abbott Laboratories and Purdue Pharma LP. The top five key players accounted for approximately 57.8% revenue share in 2019, while the remaining players accounted for over 40% of the revenue. Manufacturers are concentrating on research and development to launch new branded generic products to create incremental dollar opportunities by targeting emerging economies.
Some market players are also resorting to online sales platforms for marketing over-the-counter laxative brands. Less prominent players are concentrating on mergers and acquisitions in order to establish market presence. For instance, in 2018, Mallinckrodt Pharmaceuticals acquired Sucampo Pharmaceuticals to leverage their industry leading capabilities and R&D capabilities to accelerate innovation.
Access our latest COVID-19 impact insights on the constipation laxative market by requesting for a report sample here
COVID-19’s Impact on Constipation Laxatives Market:
The coronavirus outbreak is a human tragedy, affecting millions of people worldwide. Even today, COVID-19 is continuously expanding its tentacles, paralyzing all economic activity and hindering production capabilities. The International Monetary Fund has estimated that global growth is anticipated to fall by 3% throughout the remainder of 2020. Additionally, cost of raw materials to manufacture important drugs has augmented. Based on these trends, it is prudent to conclude that the world is headed towards a massive recession in the coming months.
Fortunately, the impact of COVID-19 on the constipation-laxatives market has been minimal. The laxative market is flooded with different brands from leading as well as mid-sized manufacturers offering products with different dosages. Manufacturers have established strong collaborations with distribution chain partners to strengthen the supply chain of laxative products for adult patients suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic conditions. This continuity of the supply chain is anticipated to keep the constipation-laxative market afloat throughout the duration of the pandemic.
Analyst’s Viewpoint:
“Rising adoption of sedentary lifestyles has led to a reduced intake of water by individuals in the wake of reduced physical activity. As a consequence, incidence of constipation has increased in both the developing and developed countries. This is expected to burgeon market prospects in the future.”
Global Constipation Laxative Market: Report Scope:
The recent study undertaken by Fact.MR on the global constipation laxative market offers a decade-long forecast ranging from 2020 to 2030 and a historical analysis from 2015 to 2020. The report explicates on vital dynamics such as the drivers, opportunities and restraints impacting future growth of the market. The market has been analyzed in detail based on the following segments: Mode of Mechanism, Route of Administration and Distribution Channel.
A regional landscape has also been mapped, providing a region-wise analysis of the abovementioned segments. Regional profiling has been done based on the following regions: North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa. Towards the end of the report, a competitive landscape highlighting key players’ revenue and market share, product launches, key collaborations and mergers and acquisitions has been provided. In addition, a SWOT analysis of each players has been incorporated to provide a realistic outlook.
Global Constipation Laxative Market – Scope of the Report
The global constipation laxative market is anticipated to witness a notable upsurge during the forecast period 2020 to 2030, conferring to a new Fact.MR study. The study promotes crucial trends that are presently determining the growth of constipation laxative market. This newly published and perceptive report sheds light on vital dynamics, which are likely to convert the future of constipation laxative market, in turn generating worthwhile opportunities for key companies as well as evolving players who are interested in the manufacturing of constipation laxative.
Constipation laxative market study is a detailed market intellect on key revenue progression factors, challenges, industry trends, and opportunities, which will eventually influence the growth of constipation laxative market. The report primarily conveys a summary of the constipation laxative market, considering present and upcoming constipation laxative industry scenarios, to reveal striking sides relating to the acceptance of constipation laxative across prominent regional markets.
A detailed assessment on few of the constipation laxative raw material suppliers accessible in the report allows the report readers to obtain detailed findings that have resulted from constipation laxative supply chain analysis, business execution, and value chain analysis across the regional markets incorporated in the report. A list of prominent companies functioning within the constipation laxative market provided in the report enhances reliability of this ample research study.
Constipation Laxative Market: Report Summary
Study offers a comprehensive overview on diverse features that are inducing demand, revenue generation and sales in constipation laxative market across the globe.
A comprehensive estimate on constipation laxative market has also been made accessible by the experts, who have considered the market estimates on the basis of a likely scenario, an optimistic scenario, and a conservative scenario regarding sales of constipation laxative during the forecast period. Analysis and estimation of price point comparison by region and by product with the global average price has been included in this study.
Constipation Laxative Market: Segmentation
FactMR’s study has done the segmentation of constipation laxative market on the basis of mode of mechanism, route of administration, distribution channel, across five regions.
|
Mode of Mechanism |
Route of Administration |
Distribution Channel |
Regions |
|
Lubricant Bulk Forming Emollient(Stool softeners) Stimulant Saline Laxatives Hyperosmotic Others |
Oral Rectal
|
Hospital Pharmacies Retail Pharmacies Drug Stores Online Pharmacies |
North America Latin America Europe South Asia East Asia Oceania Middle East & Africa |
Constipation laxative Market: Analysis on Market Size Evaluation
Predictions of constipation laxative market, encompassing current as well as forthcoming projected values estimate and analysis on region-wise demand trends and price index have been assimilated in the report.
Market estimates at the regional and global scale for constipation laxative are available in terms of value “US$ Mn” and volume “Mn Sq. Meters”. A Y-o-Y growth contrast on prominent constipation laxative market segments, along with the market attractiveness valuation computes understandings brought in the report. Metrics mentioned above are also followed based on constipation laxative applications where constipation laxative witness a steady demand.
Constipation Laxative Market: Scrutinized Assessment on Regional Segments
Weighted sections have been elaborated in the report on constipation laxative market, which delivers projection on the regional markets. These chapters brighten the regional macros (political economic, and business environment outlook), which are expected to have a significant impact on the growth of constipation laxative market during period of forecast.
Country-specific valuation on demand for constipation laxative has been offered for each regional market, along with the market scope estimate and forecast, price index, price point assessment, and impact analysis of dynamics of prominent regions and countries. For all regional markets Y-o-Y growth estimates have also been incorporated in the report.
Constipation Laxative Market: In-depth Analysis on Competitive Landscape
The report ends with a section on the competition scenario of constipation laxative market, along with the profiles of major companies contributing to the market expansion. Essential and up-to-date data as well as information correlated to the market performers, who principally engage in the production and supply of constipation laxative, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to plan preemptive steps to advance their businesses.
Company profiles have been shared with report, which exerts essentials such as product portfolio, along with an all-inclusive SWOT analysis on each player recognized along with the company policies identification and analysis. The company presence mapped and presented through the matrix for all the prominent players of the market functioning in constipation laxative market offers readers with actionable intellect, which helps in thoughtfully presenting the market status, and making decisive predictions on the competition levels in Constipation laxative market. Major companies operating in constipation laxative market are CERAMICHE ATLAS CONCORDE S.P.A, Cersanit SA, Florim Ceramiche S.P.A, Grupo Lamosa SAB de CV, Johnson Tiles and others.
Impact of Covid-19 on Constipation Laxative Market
The report includes a scenario based assessment of impact of Covid-19 across key regions for all four quarters of 2020. The report discusses the market forecast under optimistic, probabilistic and pessimistic scenario. Under the three scenarios, the demand loss and recovery has been illustrated and described through L-shaped and U-shaped recovery curves. Alongside, the Covid-19 impact has been benchmarked with previous crisis including sub-prime crisis, Eurozone crisis and SARS pandemic.
1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Management Pyramid for Patients with Chronic Constipation
4.2. Rome III Diagnostic Criteria for Adult
4.3. Patient Demography
4.4. Key Strategies Adopted by Companies Offering Constipation-Laxative
4.5. Promotional Strategies
Market Context
1.1. Value Chain Analysis
1.2. FDA Drug Approval Processes
1.3. Europe Drug Approval Process
5. Market Background
5.1. COVID19 Crisis Analysis
5.1.1. Current COVID19 Statistics and Probable Future Impact
5.1.2. Current GDP Projection and Probable Impact
5.1.3. Current Economic Projection as compared to 2008 Economic analysis
5.1.4. COVID19 and Impact Analysis
5.1.4.1. Revenue By Mode of Mechanism
5.1.4.2. Revenue By Distribution Channel
5.2. Macro-Economic Factors
5.2.1. Increase in Prevalence of Constipation
5.2.2. Burden of Chronic Constipation
5.3. Forecast Factors - Relevance & Impact
5.3.1. Rising Prevalence of Constipation in the Geriatric Population
5.3.2. Rising Obese Cases
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Trends
5.4.4. Opportunity Analysis
6. Global Constipation-Laxative Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030, By Mode of Mechanism
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) By Mode of Mechanism , 2015-2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mode of Mechanism , 2020-2030
7.3.1. Bulk-forming
7.3.2. Lubricant
7.3.3. Emollient (Stool Softeners)
7.3.4. Stimulant
7.3.5. Saline Laxative
7.3.6. Hyperosmotic
7.3.7. Others
7.4. Market Attractiveness Analysis By Mode of Mechanism
8. Global Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030, By Route of Administration
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Route of Administration, 2015-2019
8.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Type , 2020-2030
8.3.1. Oral
8.3.2. Rectal
8.4. Market Attractiveness Analysis By Route of Administration
9. Global Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020-2030
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Drug Stores
9.3.4. Online Pharmacies
9.4. Market Attractiveness Analysis By Distribution Channel
10. Global Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019
11.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Mode of Mechanism
11.3.3. By Route of Administration
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.5. Drivers and Restraints - Impact Analysis
12. Latin America Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019
12.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Mode of Mechanism
12.3.3. By Route of Administration
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Drivers and Restraints - Impact Analysis
13. Europe Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019
13.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy2020-2030
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Mode of Mechanism
13.3.3. By Route of Administration
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints - Impact Analysis
14. South Asia Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019
14.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy2020-2030
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Mode of Mechanism
14.3.3. By Route of Administration
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints - Impact Analysis
15. East Asia Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019
15.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Mode of Mechanism
15.3.3. By Route of Administration
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints - Impact Analysis
16. Oceania Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019
16.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Mode of Mechanism
16.3.3. By Route of Administration
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints - Impact Analysis
17. Middle East and Africa Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019
17.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. South Africa
17.3.1.4. Rest of Middle East and Africa
17.3.2. By Mode of Mechanism
17.3.3. By Route of Administration
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints - Impact Analysis
18. Key and Emerging Countries Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030
18.1. U.S. Constipation-Laxative Market Analysis
18.1.1. By Mode of Mechanism
18.1.2. By Route of Administration
18.1.3. By Distribution Channel
18.2. Canada Constipation-Laxative Market Analysis
18.2.1. By Mode of Mechanism
18.2.2. By Route of Administration
18.2.3. By Distribution Channel
18.3. Mexico Constipation-Laxative Market Analysis
18.3.1. By Mode of Mechanism
18.3.2. By Route of Administration
18.3.3. By Distribution Channel
18.4. U.K. Constipation-Laxative Market Analysis
18.4.1. By Mode of Mechanism
18.4.2. By Route of Administration
18.4.3. By Distribution Channel
18.5. Germany Constipation-Laxative Market Analysis
18.5.1. By Mode of Mechanism
18.5.2. By Route of Administration
18.5.3. By Distribution Channel
18.6. France Constipation-Laxative Market Analysis
18.6.1. By Mode of Mechanism
18.6.2. By Route of Administration
18.6.3. By Distribution Channel
18.7. Italy Constipation-Laxative Market Analysis
18.7.1. By Mode of Mechanism
18.7.2. By Route of Administration
18.7.3. By Distribution Channel
18.8. Spain Constipation-Laxative Market Analysis
18.8.1. By Mode of Mechanism
18.8.2. By Route of Administration
18.8.3. By Distribution Channel
18.9. BENELUX Constipation-Laxative Market Analysis
18.9.1. By Mode of Mechanism
18.9.2. By Route of Administration
18.9.3. By Distribution Channel
18.10. Russia Constipation-Laxative Market Analysis
18.10.1. By Mode of Mechanism
18.10.2. By Route of Administration
18.10.3. By Distribution Channel
18.11. Japan Constipation-Laxative Market Analysis
18.11.1. By Mode of Mechanism
18.11.2. By Route of Administration
18.11.3. By Distribution Channel
18.12. South Korea Constipation-Laxative Market Analysis
18.12.1. By Mode of Mechanism
18.12.2. By Route of Administration
18.12.3. By Distribution Channel
18.13. Australia Constipation-Laxative Market Analysis
18.13.1. By Mode of Mechanism
18.13.2. By Route of Administration
18.13.3. By Distribution Channel
18.14. New Zealand Constipation-Laxative Market Analysis
18.14.1. By Mode of Mechanism
18.14.2. By Route of Administration
18.14.3. By Distribution Channel
18.15. GCC Countries Constipation-Laxative Market Analysis
18.15.1. By Mode of Mechanism
18.15.2. By Route of Administration
18.15.3. By Distribution Channel
18.16. Turkey Constipation-Laxative Market Analysis
18.16.1. By Mode of Mechanism
18.16.2. By Route of Administration
18.16.3. By Distribution Channel
18.17. South Africa Constipation-Laxative Market Analysis
18.17.1. By Route of Administration
18.17.2. By Mode of Mechanism
18.17.3. By Route of Administration
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1.1. Regional footprint of Players
19.4.1.2. Method foot print by Players
19.4.1.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Bayer AG
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.1.4. Sales Footprint
20.3.1.5. Strategy Overview
20.3.1.5.1. Marketing Strategy
20.3.1.5.2. Product Strategy
20.3.1.5.3. Channel Strategy
20.3.2. Abbott Laboratories
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.2.4. Sales Footprint
20.3.2.5. Strategy Overview
20.3.2.5.1. Marketing Strategy
20.3.2.5.2. Product Strategy
20.3.2.5.3. Channel Strategy
20.3.3. Sanofi S.A
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.3.4. Sales Footprint
20.3.3.5. Strategy Overview
20.3.3.5.1. Marketing Strategy
20.3.3.5.2. Product Strategy
20.3.3.5.3. Channel Strategy
20.3.4. GlaxoSmithKline Pharmaceuticals Ltd
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.4.4. Sales Footprint
20.3.4.5. Strategy Overview
20.3.4.5.1. Marketing Strategy
20.3.4.5.2. Product Strategy
20.3.4.5.3. Channel Strategy
20.3.5. Mallinckrodt Pharmaceuticals
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.5.4. Sales Footprint
20.3.5.5. Strategy Overview
20.3.5.5.1. Marketing Strategy
20.3.5.5.2. Product Strategy
20.3.5.5.3. Channel Strategy
20.3.6. Sebela Pharmaceuticals
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.6.4. Sales Footprint
20.3.6.5. Strategy Overview
20.3.6.5.1. Marketing Strategy
20.3.6.5.2. Product Strategy
20.3.6.5.3. Channel Strategy
20.3.7. Procter & Gamble Company.
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.7.4. Sales Footprint
20.3.7.5. Strategy Overview
20.3.7.5.1. Marketing Strategy
20.3.7.5.2. Product Strategy
20.3.7.5.3. Channel Strategy
20.3.8. Takeda Pharmaceutical Company Limited
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.8.4. Sales Footprint
20.3.8.5. Strategy Overview
20.3.8.5.1. Marketing Strategy
20.3.8.5.2. Product Strategy
20.3.8.5.3. Channel Strategy
20.3.9. Purdue Pharmaceuticals L.P
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.9.4. Sales Footprint
20.3.9.5. Strategy Overview
20.3.9.5.1. Marketing Strategy
20.3.9.5.2. Product Strategy
20.3.9.5.3. Channel Strategy
20.3.10. Sun Pharmaceutical Industries Ltd
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.10.4. Sales Footprint
20.3.10.5. Strategy Overview
20.3.10.5.1. Marketing Strategy
20.3.10.5.2. Product Strategy
20.3.10.5.3. Channel Strategy
20.3.11. Dr. Reddy’s Laboratories Ltd.
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.11.4. Sales Footprint
20.3.11.5. Strategy Overview
20.3.11.5.1. Marketing Strategy
20.3.11.5.2. Product Strategy
20.3.11.5.3. Channel Strategy
20.3.12. Cipla Ltd
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.12.4. Sales Footprint
20.3.12.5. Strategy Overview
20.3.12.5.1. Marketing Strategy
20.3.12.5.2. Product Strategy
20.3.12.5.3. Channel Strategy
20.3.13. Mankind Pharma Ltd
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.13.4. Sales Footprint
20.3.13.5. Strategy Overview
20.3.13.5.1. Marketing Strategy
20.3.13.5.2. Product Strategy
20.3.13.5.3. Channel Strategy
20.3.14. Beutlich Pharmaceuticals, LLC
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Profitability by Market Segments (Drugs/Channel/Region)
20.3.14.4. Sales Footprint
20.3.14.5. Strategy Overview
20.3.14.5.1. Marketing Strategy
20.3.14.5.2. Product Strategy
20.3.14.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Fact.MR offers custom research services that help clients to get specific research solutions
Related reports
We are committed towards customer satisfaction and quality service.
Our Clients
Fact.MR in Media
Our analysts in Media
Constipation Laxative Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2030